Vanguard Group Inc Amphastar Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,711,473 shares of AMPH stock, worth $123 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,711,473
Previous 2,672,862
1.44%
Holding current value
$123 Million
Previous $107 Million
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding AMPH
# of Institutions
287Shares Held
35.1MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$270 Million0.01% of portfolio
-
Td Asset Management Inc2.14MShares$97.1 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$88.5 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$73.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.53MShares$69.6 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.23B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...